Becton, Dickinson and Co. | BDX - Ebitda





Ebitda Cambio Fecha
Abbott USD 3.27B 178M 2025-12
Agilent USD 456M 84M 2025-12
Align Technology USD 260.87M 77.03M 2025-12
AngioDynamics USD 5.94M 3.78M 2025-09
Avanos Medical USD 13M 3M 2025-12
Baxter International USD -447M 873M 2025-12
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Bio-Rad Laboratories USD 983.8M 1.36B 2025-12
Boston Scientific USD 1.16B 213M 2025-12
Cooper Companies USD 323.4M 13.2M 2025-12
Danaher USD 1.92B 204M 2026-03
Dentsply International USD 129M 6M 2026-03
Dexcom USD 364.5M 57.7M 2026-03
Edwards Lifesciences USD 70.1M 394.2M 2025-12
Globus Medical USD 280.46M 27.86M 2025-12
Insulet USD 181.7M 12.3M 2026-03
Integra LifeSciences USD 76.18M 28.03M 2026-03
Intuitive Surgical USD 1.09B 165.5M 2025-12
J&J USD 7.19B 2.32B 2025-12
Medtronic USD 2.81B 119M 2026-03
Solventum Corp USD 437M 0 2026-03
Stryker USD 1.57B 618M 2026-03
Tandem Diabetes Care USD 2.73M 30.17M 2026-03
Teleflex USD 247.07M 575.88M 2025-12
Terumo JPY 57.88B 12.1B 2026-03
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Zimmer Biomet Holdings USD 759M 120.8M 2025-12